Xenon Pharmaceuticals Inc. Profile Avatar - Palmy Investing

Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is …
Biotechnology
CA, Burnaby [HQ]
Strategy & Leadership

Qualitative Analysis

Business

Framework: SWOT 7's
End of XENE's Analysis
CIK: 1582313 CUSIP: 98420N105 ISIN: CA98420N1050 LEI: - UEI: -
Secondary Listings
XENE has no secondary listings inside our databases.